The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
Expression of NKG2D immunoreceptor ligands on tumour cells is believed to inhibit tumour growth through engaging NKG2D-expressing immune cells. Here, the authors show that in a model of liver cancer the NKG2D/NKG2D-ligand pathway can also promote tumour formation by sustaining an inflammatory enviro...
Guardado en:
Autores principales: | Sam Sheppard, Joana Guedes, Anna Mroz, Anastasia-Maria Zavitsanou, Hiromi Kudo, Stephen M. Rothery, Panagiotis Angelopoulos, Robert Goldin, Nadia Guerra |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/19101936214342739334b5deafccc5f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profiling of tumour-associated microbiota in human hepatocellular carcinoma
por: Seiga Komiyama, et al.
Publicado: (2021) -
Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment
por: Aiping Chen, et al.
Publicado: (2017) -
Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation
por: Sanae Ben Mkaddem, et al.
Publicado: (2017) -
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
por: Phuong H. D. Nguyen, et al.
Publicado: (2021) -
Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma
por: Tamás Sükei, et al.
Publicado: (2021)